Shifting the Narrative of Preexposure Prophylaxis Adherence Counseling for Cisgender Women

Anandi N Sheth^{1

2}, Florence Momplaisir^{3

4}, Julie B Dumond⁵

Affiliations

¹ Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
² Ponce de Leon Center, Grady Health System, Atlanta, Georgia.
³ Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
⁴ The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
⁵ Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.

Comment

Anandi N Sheth et al. JAMA. 2024.

. 2024 Mar 19;331(11):912-914.

doi: 10.1001/jama.2024.0432.

Anandi N Sheth^{1

2}, Florence Momplaisir^{3

4}, Julie B Dumond⁵

¹ Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, Georgia.
² Ponce de Leon Center, Grady Health System, Atlanta, Georgia.
³ Division of Infectious Diseases, Department of Medicine, Perelman School of Medicine, University of Pennsylvania, Philadelphia.
⁴ The Leonard Davis Institute of Health Economics, University of Pennsylvania, Philadelphia.
⁵ Division of Pharmacotherapy and Experimental Therapeutics, Eshelman School of Pharmacy, University of North Carolina at Chapel Hill.

No abstract available

Comment on

HIV Preexposure Prophylaxis With Emtricitabine and Tenofovir Disoproxil Fumarate Among Cisgender Women.
Marrazzo J, Tao L, Becker M, Leech AA, Taylor AW, Ussery F, Kiragu M, Reza-Paul S, Myers J, Bekker LG, Yang J, Carter C, de Boer M, Das M, Baeten JM, Celum C. Marrazzo J, et al. JAMA. 2024 Mar 19;331(11):930-937. doi: 10.1001/jama.2024.0464. JAMA. 2024. PMID: 38427359 Free PMC article.